Senti Biosciences, Inc. COM NEW
Senti Biosciences, Inc. COM NEW is a security (CUSIP 81726A209) tracked across SEC portfolio filings. 15 institutional managers reported $4.7M on Form 13F as of 2026-03-31; 2 registered fund positions totaling $137K via N-PORT as of 2026-03-31.
Summary
- Issuer: Senti Biosciences, Inc.
- Class: COM NEW
- CUSIP: 81726A209
- Asset category: EC
- 13F holders: 15
- 13F value: $4.7M
- 13F period: 2026-03-31
- N-PORT fund positions: 2
- N-PORT value: $137K
- N-PORT report: 2026-03-31
Top institutional holders (Form 13F)
| Manager | Location | Value | Shares |
|---|
| NEA Management Company, LLC | TIMONIUM, MD | $3.1M | 3,775,615 |
| Nantahala Capital Management, LLC | New Canaan, CT | $721K | 888,000 |
| VANGUARD GROUP INC | Valley Forge, PA | $654K | 628,697 |
| GEODE CAPITAL MANAGEMENT, LLC | BOSTON, MA | $168K | 207,043 |
| MSOP GP, L.L.C. | MENLO PARK, CA | $37K | 35,737 |
| Menlo Ventures Management, L.P. | MENLO PARK, CA | $29K | 35,737 |
| BlackRock, Inc. | New York, NY | $20K | 25,074 |
| XTX Topco Ltd | LONDON, X0 | $14K | 17,277 |
| NORTHERN TRUST CORP | CHICAGO, IL | $14K | 16,778 |
| NewEdge Advisors, LLC | New Orleans, LA | $10K | 12,000 |
| STATE STREET CORP | BOSTON, MA | $8K | 10,010 |
| UBS Group AG | Zurich, V8 | $7K | 8,637 |
| MORGAN STANLEY | NEW YORK, NY | $130 | 160 |
| HRT FINANCIAL LP | NEW YORK, NY | $12 | 14,844 |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | BIRMINGHAM, AL | — | 0 |
Top fund holders (N-PORT)
More